{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:25:40Z","timestamp":1793060740027,"version":"4.5.0"},"reference-count":5,"publisher":"Massachusetts Medical Society","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2023,6,15]]},"DOI":"10.1056\/nejmp2303120","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T21:00:16Z","timestamp":1682542816000},"page":"2209-2212","source":"Crossref","is-referenced-by-count":155,"title":["Xylazine \u2014 Medical and Public Health Imperatives"],"prefix":"10.1056","volume":"388","author":[{"given":"Rahul","family":"Gupta","sequence":"first","affiliation":[{"name":"From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia (M.A.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Holtgrave","sequence":"additional","affiliation":[{"name":"From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia (M.A.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Ashburn","sequence":"additional","affiliation":[{"name":"From the White House Office of National Drug Control Policy, Washington, DC (R.G., D.R.H., M.A.A.); and the Department of Anesthesiology and Critical Care, University of Pennsylvania, Philadelphia (M.A.A.)."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"150","reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.2022.306881"},{"key":"e_1_3_4_3_2","unstructured":"Philadelphia Department of Public Health. Substance use Philly: xylazine. (https:\/\/www.substanceusephilly.com\/tranq)."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/jat\/bkac049"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000955"},{"issue":"8","key":"e_1_3_4_6_2","first-page":"e28160","article-title":"Xylazine-induced skin ulcers in a person who injects drugs in Philadelphia, Pennsylvania, USA.","volume":"14","author":"Malayala SV","year":"2022","unstructured":"Malayala SV, Papudesi BN, Bobb R, Wimbush A. Xylazine-induced skin ulcers in a person who injects drugs in Philadelphia, Pennsylvania, USA. Cureus 2022;14(8):e28160-e28160.36148197","journal-title":"Cureus"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMp2303120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:55:36Z","timestamp":1749682536000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMp2303120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,15]]},"references-count":5,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2023,6,15]]}},"alternative-id":["10.1056\/NEJMp2303120"],"URL":"https:\/\/doi.org\/10.1056\/nejmp2303120","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,15]]}}}